Rapport Therapeutics Ratios (2024-2026) | RAPP

Ratios Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
EBT Margin (Quarter) -718.46%
EBIT Margin (Quarter) -121.08%
EBITDA Margin (Quarter) -121.08%
Operating Margin (Quarter) -121.08%
Net Margin (Quarter) -99.29%
FCF Margin (Quarter) -65.74%
Efficiency
Assets Average (Quarter) 338.62M323.04M308.49M293.77M410.41M523.88M505.01M478.29M
Asset Utilization Ratio (Quarter) 0.04
Leverage & Solvency
Interest Coverage Ratio (Quarter) -0.30
Times Interest Earned (Quarter) -0.30
Valuation
Enterprise Value (Quarter) -436.08M
Return Ratios
Return on Sales (Quarter) -0.34%
Return on Capital Employed (Quarter) -34.12%
Return on Assets (Quarter) -0.01%